Global Biopharmaceuticals Market Outlook, 2029

The Global Biopharmaceuticals Market is projected to reach a staggering USD 1.2 trillion by 2032, driven by rise in healthcare expenditure.

According to publisher, Here is the global biopharmaceuticals market is experiencing a significant surge, driven by advancements in biotechnology and growing demand for targeted therapies. The market size is projected to reach a staggering USD 1.2 trillion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of a healthy 8.8%. Here's a quick injection of insights into this dynamic market: Market Insights

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Shifting Treatment Landscape: Biopharmaceuticals are revolutionizing medicine by offering targeted therapies for chronic diseases like cancer, diabetes, and autoimmune disorders. Examples include monoclonal antibodies that precisely target cancer cells and gene therapies that address genetic mutations causing diseases. Aging Population: The growing global population and increasing life expectancy fuel the demand for treatments for age-related diseases, a key driver for the biopharmaceuticals market. Market Dynamics

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Drivers: Rising Healthcare Expenditure: Increased government and private healthcare spending globally creates opportunities for innovative biopharmaceutical products. Technological Advancements: Breakthroughs in gene editing, artificial intelligence, and personalized medicine are accelerating the development of novel biopharmaceuticals.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Restraints: High Cost of Development: Bringing biopharmaceuticals to market is expensive due to rigorous clinical trials and regulatory requirements. This can limit access for some patients. Patent Expirations: As patents on existing biopharmaceuticals expire, generic versions can enter the market, potentially impacting revenue for original developers. Market Segments Product Type: Monoclonal Antibodies: Dominate the market, offering targeted therapies for various diseases. (e.g., Rituximab for certain cancers) Vaccines: A crucial segment, with continuous development for new and improved vaccines against infectious diseases. (e.g., recent COVID-19 vaccines) Gene Therapies: A rapidly growing segment with the potential to cure genetic diseases. (e.g., Kymriah for certain leukemias) Application: Oncology: The largest application segment due to the high prevalence of cancer and the increasing availability of targeted therapies. Autoimmune Diseases: Biopharmaceuticals offer promising treatment options for diseases like rheumatoid arthritis and multiple sclerosis. Neurological Disorders: Growing research focuses on developing biopharmaceuticals for Alzheimer's disease, Parkinson's disease, and other neurological conditions. Regional Analysis North America Leads: The United States is the dominant market due to strong research and development capabilities, a well-developed healthcare system, and high patient spending. Asia Pacific on the Rise: The region is witnessing significant growth due to a large patient population, rising disposable income, and government investments in biotechnology. China and India are key players. Europe Remains Strong: Europe has a robust biopharmaceutical industry with a focus on innovation and a well-established regulatory framework. Key Developments Biosimilars: The development of biosimilars, which are highly similar versions of existing biopharmaceuticals, offers more affordable treatment options for patients. Precision Medicine: This approach tailors biopharmaceutical treatments to a patient's specific genetic makeup, offering more effective and personalized therapies. Contract Manufacturing: Biopharmaceutical companies are increasingly outsourcing manufacturing to contract manufacturing organizations (CMOs) to optimize production costs and efficiency. Competitive Landscape Big Pharma and Biotech Startups: Major pharmaceutical companies like Roche and Pfizer compete alongside innovative biotech startups developing next-generation biopharmaceuticals. Focus on Mergers & Acquisitions: Consolidation is occurring within the industry as companies seek to expand their product portfolios and access new technologies. Collaboration for Innovation: Partnerships between biopharmaceutical companies, academic institutions, and research organizations are accelerating drug discovery and development. Future Outlook The global biopharmaceuticals market is brimming with potential, driven by: Continued R&D: Breakthroughs in biotechnology will lead to the development of even more effective and targeted biopharmaceuticals. Focus on Affordability: Strategies to reduce development costs and improve access to biopharmaceuticals will be crucial for wider adoption. Emerging Markets: Growth in developing countries will be significant as healthcare infrastructure improves and disposable incomes rise. The future of biopharmaceuticals holds immense promise for improving human health and tackling complex diseases. This market will continue to evolve at a rapid pace, shaping the way we treat and prevent diseases for years to come.

Table of Contents

  • 1 Introduction 11
  • 1.1 Industry Definition and Research Scope 11
  • 1.1.1 Industry Definition 11
  • 1.1.2 Research Scope 12
  • 1.2 Research Methodology 15
  • 1.2.1 Overview of Market Research Methodology 15
  • 1.2.2 Market Assumption 16
  • 1.2.3 Secondary Data 16
  • 1.2.4 Primary Data 16
  • 1.2.5 Data Filtration and Model Design 17
  • 1.2.6 Market Size/Share Estimation 18
  • 1.2.7 Research Limitations 19
  • 1.3 Executive Summary 20
  • 2 Market Overview and Dynamics 23
  • 2.1 Market Size and Forecast 23
  • 2.1.1 Impact of COVID-19 on World Economy 24
  • 2.1.2 Impact of COVID-19 on the Market 28
  • 2.1.3 Impact of Russia-Ukraine Conflict 30
  • 2.1.4 Impact of Israel-Palestine War 32
  • 2.2 Major Growth Drivers 33
  • 2.3 Market Restraints and Challenges 42
  • 2.4 Emerging Opportunities and Market Trends 45
  • 2.5 Porter’s Fiver Forces Analysis 49
  • 3 Segmentation of Global Market by Product Type 53
  • 3.1 Market Overview by Product Type 53
  • 3.2 Monoclonal Antibodies 55
  • 3.2.1 Anti-cancer Monoclonal Antibodies 56
  • 3.2.2 Anti-inflammatory Monoclonal Antibodies 57
  • 3.2.3 Other Monoclonal Antibodies 58
  • 3.3 Recombinant Growth Factors 59
  • 3.3.1 Erythropoietin 60
  • 3.3.2 Granulocyte Colony Stimulating Factor 61
  • 3.4 Purified Proteins 62
  • 3.4.1 Leukemia Inhibitory Factor (LIF) 63
  • 3.4.2 P53 Protein 64
  • 3.4.3 P38 Protein 65
  • 3.4.4 Other Purified Proteins 66
  • 3.5 Recombinant Proteins 67
  • 3.5.1 Serum Albumin 68
  • 3.5.2 Amyloid Protein 69
  • 3.5.3 Defensin 70
  • 3.5.4 Transferrin 71
  • 3.6 Recombinant Hormones 72
  • 3.6.1 Recombinant Human Growth Hormones 73
  • 3.6.2 Recombinant Insulin 75
  • 3.6.3 Other Recombinant Hormones 76
  • 3.7 Vaccines 77
  • 3.7.1 Recombinant Vaccines 78
  • 3.7.2 Conventional Vaccines 80
  • 3.8 Recombinant Enzymes 81
  • 3.8.1 Enterokinase 82
  • 3.8.2 Cyclase 83
  • 3.8.3 Caspase 84
  • 3.8.4 Cathepsin 85
  • 3.9 Cell and Gene Therapies 86
  • 3.9.1 Allogenic Products 87
  • 3.9.2 Autologous Products 88
  • 3.9.3 Acellular Products 89
  • 3.10 Synthetic Immunomodulators 90
  • 3.11 Other Product Types 91
  • 3.11.1 Blood Factors 92
  • 3.11.2 Other Products 93
  • 4 Segmentation of Global Market by Testing Service 94
  • 4.1 Market Overview by Testing Service 94
  • 4.2 Laboratory Testing 96
  • 4.3 Custom Testing/Customer Proprietary Testing 97
  • 4.4 Compendial and Multi Compendial Laboratory Testing 98
  • 5 Segmentation of Global Market by Raw Material 99
  • 5.1 Market Overview by Raw Material 99
  • 5.2 Formulation Excipients 101
  • 5.3 Active Pharmaceutical Ingredients (API) 102
  • 5.4 Other Materials 103
  • 6 Segmentation of Global Market by Classification 104
  • 6.1 Market Overview by Classification 104
  • 6.2 Innovative Biopharmaceuticals 106
  • 6.3 Biogenerics and Biosimilars 107
  • 7 Segmentation of Global Market by Therapeutic Area 108
  • 7.1 Market Overview by Therapeutic Area 108
  • 7.2 Oncology 110
  • 7.3 Inflammatory and Infectious Diseases 111
  • 7.4 Autoimmune Disorders 112
  • 7.5 Metabolic Disorders 113
  • 7.6 Hormonal Disorders 114
  • 7.7 Cardiovascular Diseases 115
  • 7.8 Neurological Diseases 116
  • 7.9 Other Therapeutic Areas 117
  • 8 Segmentation of Global Market by Region 118
  • 8.1 Geographic Market Overview 2023-2033 118
  • 8.2 North America Market 2023-2033 by Country 122
  • 8.2.1 Overview of North America Market 122
  • 8.2.2 U.S. 126
  • 8.2.3 Canada 129
  • 8.2.4 Mexico 131
  • 8.3 European Market 2023-2033 by Country 133
  • 8.3.1 Overview of European Market 133
  • 8.3.2 Germany 137
  • 8.3.3 U.K. 139
  • 8.3.4 France 141
  • 8.3.5 Spain 143
  • 8.3.6 Italy 145
  • 8.3.7 Netherlands 147
  • 8.3.8 Rest of European Market 149
  • 8.4 Asia-Pacific Market 2023-2033 by Country 151
  • 8.4.1 Overview of Asia-Pacific Market 151
  • 8.4.2 Japan 155
  • 8.4.3 China 158
  • 8.4.4 Australia 160
  • 8.4.5 India 162
  • 8.4.6 South Korea 164
  • 8.4.7 Rest of APAC Region 166
  • 8.5 South America Market 2023-2033 by Country 168
  • 8.5.1 Argentina 171
  • 8.5.2 Brazil 173
  • 8.5.3 Chile 175
  • 8.5.4 Rest of South America Market 177
  • 8.6 MEA Market 2023-2033 by Country 178
  • 8.6.1 UAE 181
  • 8.6.2 Saudi Arabia 183
  • 8.6.3 South Africa 185
  • 8.6.4 Other National Markets 187
  • 9 Competitive Landscape 188
  • 9.1 Overview of Key Vendors 188
  • 9.2 New Product Launch, Partnership, Investment, and M&A 192
  • 9.3 Company Profiles 193
  • Abbott Laboratories 193
  • Amgen Inc. 195
  • Astrazeneca PLC 196
  • Bayer AG 197
  • Biogen Inc. 198
  • Bristol-myers Squibb Company (BMS) 199
  • Eli Lilly and Company 200
  • F. Hoffmann-La Roche Ltd. 201
  • Glaxosmithkline PLC 202
  • Johnson & Johnson 203
  • Merck & Co. Inc. 204
  • Novartis Ag 205
  • Novo Nordisk As 206
  • Pfizer Inc. 207
  • Sanofi Sa 208
  • Sharp Packaging Services 209
  • Sun Pharmaceutical Industries Ltd. 210
  • Takeda Pharmaceutical Company Limited 211
  • Thermo Fisher Scientific Inc. 212
  • Vertex Pharmaceuticals 213
  • WuXi AppTec 214
  • RELATED REPORTS 215



Table 1. Snapshot of Global Biopharmaceuticals Market in Balanced Perspective, 2023-2033 21
Table 2. World Economic Outlook, 2024-2036 25
Table 3. World Economic Outlook, 2022-2024 27
Table 4. Scenarios for Economic Impact of Ukraine Crisis 31
Table 5. Scenarios for Economic Impact of Israel-Palestine War 32
Table 6. World Health Spending by Region, $ bn, 2013-2020 37
Table 7. Total Number of Registered Clinical Studies Worldwide, 2010-2021 38
Table 8. Worldwide Number of New Cancer by Type, 2020 39
Table 9. Main Product Trends and Market Opportunities in Global Biopharmaceuticals Market 45
Table 10. Global Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 53
Table 11. Global Biopharmaceuticals Market: Monoclonal Antibodies by Type, 2023-2033, $ mn 55
Table 12. Global Biopharmaceuticals Market: Recombinant Growth Factor by Type, 2023-2033, $ mn 59
Table 13. Global Biopharmaceuticals Market: Purified Proteins by Type, 2023-2033, $ mn 62
Table 14. Global Biopharmaceuticals Market: Recombinant Proteins by Type, 2023-2033, $ mn 67
Table 15. Global Biopharmaceuticals Market: Recombinant Hormones by Type, 2023-2033, $ mn 72
Table 16. Selected Drugs for COVID-19 Treatment in Development, Nov 2022 74
Table 17. Global Biopharmaceuticals Market: Vaccines by Type, 2023-2033, $ mn 77
Table 18. Global Biopharmaceuticals Market: Recombinant Vaccines by Type, 2023-2033, $ mn 79
Table 19. Global Biopharmaceuticals Market: Conventional Vaccines by Type, 2023-2033, $ mn 80
Table 20. Global Biopharmaceuticals Market: Recombinant Enzymes by Type, 2023-2033, $ mn 81
Table 21. Global Biopharmaceuticals Market: Cell and Gene Therapies by Type, 2023-2033, $ mn 86
Table 22. Global Biopharmaceuticals Market: Other Product Types by Type, 2023-2033, $ mn 91
Table 23. Global Biopharmaceuticals Market by Testing Service, 2023-2033, $ mn 94
Table 24. Global Biopharmaceuticals Market by Raw Material, 2023-2033, $ mn 99
Table 25. Global Biopharmaceuticals Market by Classification, 2023-2033, $ mn 104
Table 26. Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 108
Table 27. Global Biopharmaceuticals Market by Region, 2023-2033, $ mn 119
Table 28. Leading National Biopharmaceuticals Market, 2023 and 2033, $ mn 121
Table 29. North America Biopharmaceuticals Market by Country, 2023-2033, $ mn 124
Table 30. U.S. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 128
Table 31. U.S. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 128
Table 32. Canada Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 130
Table 33. Canada Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 130
Table 34. Mexico Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 132
Table 35. Mexico Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 132
Table 36. Europe Biopharmaceuticals Market by Country, 2023-2033, $ mn 136
Table 37. Germany Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 138
Table 38. Germany Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 138
Table 39. U.K. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 140
Table 40. U.K. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 140
Table 41. France Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 142
Table 42. France Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 142
Table 43. Spain Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 144
Table 44. Spain Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 144
Table 45. Italy Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 146
Table 46. Italy Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 146
Table 47. Netherlands Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 148
Table 48. Netherlands Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 148
Table 49. Biopharmaceuticals Market in Rest of Europe by Country, 2023-2033, $ mn 150
Table 50. APAC Biopharmaceuticals Market by Country, 2023-2033, $ mn 153
Table 51. Japan Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 157
Table 52. Japan Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 157
Table 53. China Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 159
Table 54. China Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 159
Table 55. Australia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 161
Table 56. Australia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 161
Table 57. India Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 163
Table 58. India Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 163
Table 59. South Korea Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 165
Table 60. South Korea Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 165
Table 61. Biopharmaceuticals Market in Rest of APAC by Country/Region, 2023-2033, $ mn 167
Table 62. South America Biopharmaceuticals Market by Country, 2023-2033, $ mn 170
Table 63. Argentina Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 172
Table 64. Argentina Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 172
Table 65. Brazil Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 174
Table 66. Brazil Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 174
Table 67. Chile Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 176
Table 68. Chile Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 176
Table 69. MEA Biopharmaceuticals Market by Country, 2023-2033, $ mn 180
Table 70. UAE Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 182
Table 71. UAE Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 182
Table 72. Saudi Arabia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 184
Table 73. Saudi Arabia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 184
Table 74. South Africa Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 186
Table 75. South Africa Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 186
Table 76. Abbott Laboratories: Company Snapshot 193
Table 77. Abbott Laboratories: Business Segmentation 194
Table 78. Abbott Laboratories: Product Portfolio 194



Figure 1. Research Method Flow Chart 15
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 20
Figure 4. Global Biopharmaceuticals Market, 2023-2033, $ mn 23
Figure 5. Impact of COVID-19 on Business 28
Figure 6. Primary Drivers and Impact Factors of Global Biopharmaceuticals Market 33
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 36
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022 37
Figure 10. Primary Restraints and Impact Factors of Global Biopharmaceuticals Market 42
Figure 11. Investment Opportunity Analysis 46
Figure 12. Porter’s Fiver Forces Analysis of Global Biopharmaceuticals Market 49
Figure 13. Breakdown of Global Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue 54
Figure 14. Global Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%) 54
Figure 15. Global Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn 55
Figure 16. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn 56
Figure 17. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn 57
Figure 18. Global Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn 58
Figure 19. Global Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn 59
Figure 20. Global Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn 60
Figure 21. Global Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn 61
Figure 22. Global Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn 62
Figure 23. Global Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn 63
Figure 24. Global Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn 64
Figure 25. Global Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn 65
Figure 26. Global Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn 66
Figure 27. Global Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn 67
Figure 28. Global Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn 68
Figure 29. Global Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn 69
Figure 30. Global Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn 70
Figure 31. Global Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn 71
Figure 32. Global Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn 72
Figure 33. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn 73
Figure 34. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn 75
Figure 35. Global Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn 76
Figure 36. Global Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn 77
Figure 37. Global Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn 78
Figure 38. Global Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn 80
Figure 39. Global Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn 81
Figure 40. Global Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn 82
Figure 41. Global Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn 83
Figure 42. Global Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn 84
Figure 43. Global Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn 85
Figure 44. Global Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn 86
Figure 45. Global Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn 87
Figure 46. Global Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn 88
Figure 47. Global Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn 89
Figure 48. Global Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn 90
Figure 49. Global Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn 91
Figure 50. Global Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn 92
Figure 51. Global Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn 93
Figure 52. Breakdown of Global Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue 95
Figure 53. Global Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%) 95
Figure 54. Global Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn 96
Figure 55. Global Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn 97
Figure 56. Global Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn 98
Figure 57. Breakdown of Global Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue 100
Figure 58. Global Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%) 100
Figure 59. Global Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn 101
Figure 60. Global Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn 102
Figure 61. Global Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn 103
Figure 62. Breakdown of Global Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue 105
Figure 63. Global Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%) 105
Figure 64. Global Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn 106
Figure 65. Global Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn 107
Figure 66. Breakdown of Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue 109
Figure 67. Global Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%) 109
Figure 68. Global Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn 110
Figure 69. Global Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn 111
Figure 70. Global Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn 112
Figure 71. Global Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn 113
Figure 72. Global Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn 114
Figure 73. Global Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn 115
Figure 74. Global Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn 116
Figure 75. Global Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn 117
Figure 76. Global Market Snapshot by Region 118
Figure 77. Geographic Spread of Worldwide Biopharmaceuticals Market, 2023-2033, % of Sales Revenue 119
Figure 78. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%) 120
Figure 79. North American Biopharmaceuticals Market, 2023-2033, $ mn 123
Figure 80. Breakdown of North America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 124
Figure 81. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 125
Figure 82. U.S. Biopharmaceuticals Market, 2023-2033, $ mn 127
Figure 83. Venture Capital Deal Activity and Investment Flows in the U.S., 2013-2022, $ bn and Deal Counts 127
Figure 84. Canada Biopharmaceuticals Market, 2023-2033, $ mn 129
Figure 85. Biopharmaceuticals Market in Mexico, 2023-2033, $ mn 131
Figure 86. European Biopharmaceuticals Market, 2023-2033, $ mn 134
Figure 87. Breakdown of European Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 135
Figure 88. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 136
Figure 89. Biopharmaceuticals Market in Germany, 2023-2033, $ mn 137
Figure 90. Biopharmaceuticals Market in U.K., 2023-2033, $ mn 139
Figure 91. Biopharmaceuticals Market in France, 2023-2033, $ mn 141
Figure 92. Biopharmaceuticals Market in Spain, 2023-2033, $ mn 143
Figure 93. Biopharmaceuticals Market in Italy, 2023-2033, $ mn 145
Figure 94. Biopharmaceuticals Market in Netherlands, 2023-2033, $ mn 147
Figure 95. Biopharmaceuticals Market in Rest of Europe, 2023-2033, $ mn 149
Figure 96. Asia-Pacific Biopharmaceuticals Market, 2023-2033, $ mn 152
Figure 97. Breakdown of APAC Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 152
Figure 98. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 154
Figure 99. Biopharmaceuticals Market in Japan, 2023-2033, $ mn 156
Figure 100. Biopharmaceuticals Market in China, 2023-2033, $ mn 158
Figure 101. Biopharmaceuticals Market in Australia, 2023-2033, $ mn 160
Figure 102. Biopharmaceuticals Market in India, 2023-2033, $ mn 162
Figure 103. Biopharmaceuticals Market in South Korea, 2023-2033, $ mn 164
Figure 104. Biopharmaceuticals Market in Rest of APAC, 2023-2033, $ mn 166
Figure 105. South America Biopharmaceuticals Market, 2023-2033, $ mn 169
Figure 106. Breakdown of South America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 169
Figure 107. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 170
Figure 108. Biopharmaceuticals Market in Argentina, 2023-2033, $ mn 171
Figure 109. Biopharmaceuticals Market in Brazil, 2023-2033, $ mn 173
Figure 110. Biopharmaceuticals Market in Chile, 2023-2033, $ mn 175
Figure 111. Biopharmaceuticals Market in Rest of South America, 2023-2033, $ mn 177
Figure 112. Biopharmaceuticals Market in Middle East and Africa (MEA), 2023-2033, $ mn 179
Figure 113. Breakdown of MEA Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 179
Figure 114. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 180
Figure 115. Biopharmaceuticals Market in UAE, 2023-2033, $ mn 181
Figure 116. Biopharmaceuticals Market in Saudi Arabia, 2023-2033, $ mn 183
Figure 117. Biopharmaceuticals Market in South Africa, 2023-2033, $ mn 185
Figure 118. Growth Stage of Global Biopharmaceuticals Industry over the Forecast Period 188
Figure 119. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn 190
Logo

Global Biopharmaceuticals Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.